POST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2): MULTISYSTEM INFLAMMATORY SYNDROME IN ADULTS (MIS-A) MIMICKING A FUNGAL INFECTION

*Dr. Arushi Mohan- Resident, Dr. Brunda MS, Dr. Aathira Raveen, Dr. Rohit Goyal, Dr. Ramesh Acharya, Dr. Syed Mohammed Emad Uddin

ABSTRACT

Multisystem inflammatory syndrome, a multifaceted condition seen mostly in children after COVID-19 infection (Coronavirus disease -19), was first reported in the UK in April 2020. Since then, it has been fringing into the adult population, with cases being reported since June 2020. The clinical manifestations of the condition are widespread involving multiple systems such as mucocutaneous, cardiac, gastrointestinal, hematological and neurological system. These symptoms are associated with elevated inflammatory markers, the persistence of fever, and signs of shock. In addition, the respiratory system that is typically involved in patients with SARS-CoV-2 is not always seen in the MIS. MIS-A not only differs in the involved age group from MIS-C, but it also tends to be more severe, given the underlying medical conditions and a probable frail immune system.[1,2] Differentiating MIS-A from acute COVID-19 infection is grueling. While evaluating the patients with severe COVID-19 infection, physicians should also have a high degree of suspicion for MIS-A, because of a high proportion of patients may be suffering from MIS-A.[3] We will be describing how a rare case of MIS-A, unraveled by multiple brainstorming differentials ameliorated with the administration of steroids, stressing the importance of a focused diagnosis.

Keywords: Differentiating MIS-A from acute COVID-19 infection is grueling.